Skip to main content

383 publications

Name Date Type Actions

3rd quarter revenues confirm promise of
strong growth prospects for 2007

For the nine months ended September 30, 2007, Vétoquinol’s total revenues reached €166.0 M, an increase of 11.3% compared with the
corresponding period in 2006.

25/10/2007 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital

15/11/2007 Voting rights

Vétoquinol to market and distribute Vetprofen in the United States

28/11/2007 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital

12/12/2007 Voting rights

Vétoquinol announces opening of its first decentralized R&D center in Canada

17/12/2007 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital

09/01/2008 Voting rights

Revenue grows by 10.3% in 2007, to €233.4 M

24/01/2008 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital

12/02/2008 Voting rights

KIBOW BIOTECH INC. et Vétoquinol S.A. étendent leur accord de commercialisation et de licence vétérinaire pour des applications mondiales (french)

25/02/2008 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital

07/03/2008 Voting rights